Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
The FDA and the NTIA are launching a 120-day pilot to help reduce the availability of unapproved opioids illegally offered for sale online.
read more
Eleva is exploring the potential of one of its drug candidates for first-in-line therapy of COVID-19.
read more
Celerion announced the expansion of specialized high-resolution mass spectrometry (HR-MS) profiling capabilities.
read more
AstraZeneca will collaborate with Accent Therapeutics to discover, develop and commercialize therapeutics targeting RNA-modifying proteins (RMPs) for the treatment of cancer.
read more
Ryvu Therapeutics has signed a grant agreement with the National Centre for Research and Development for the development of targeted immuno-oncology therapy.
read more
The PolyPeptide Group has partnered with Novavax on large-scale GMP production of a critical component of Novavax’ novel coronavirus vaccine candidate, NVX-CoV2373.
read more
Jounce Therapeutics has regained the worldwide rights to JTX-8064 from Bristol Myers Squibb.
read more
Almac Group has welcomed confirmation from the EU’s medicines regulator, the EMA, that, post-Brexit, Northern Ireland will remain in regulatory alignment with the EU.
read more
Access Medical Labs will run the Siemens Health FDA Authorized reagent under their EUA at its State of the Art Facility in Jupiter, FL.
read more
Celerion has announced the multimillion-dollar expansion of specialized pharmacies across their clinical research units in North America.
read more
Seven Bridges announced the successful completion of independent examinations for SOC 2 Type 2, SOC 3 and HIPAA.
read more
The FDA is making its previously developed MyStudies app available to investigators to obtain informed consent securely from patients for eligible clinical trials when face-to-face contact is not possible or practical due to COVID-19 control measures...
read more
IonSense and WHALE Biolabs announced a strategic alliance to provide analytical services for chemists utilizing HTE in their laboratories.
read more
ERT announced the results of a recent industry survey that indicate an acceleration in the adoption of virtual clinical trials due to the COVID-19 pandemic.
read more
Octapharma USA is extending funding for an IIS focused on treating the most critical patients at the heart of the coronavirus pandemic, those experiencing hypoxia and who are at the highest risk of requiring mechanical ventilation.
read more